Agios Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AGIO Nasdaq 2836 www.agios.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Agios Pharmaceuticals, Inc.

Why Agios Pharmaceuticals (AGIO) Is the Top Small Cap Stock to Buy with the Highest Upside Potential - Jan 13th, 2025 9:29 pm
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio - Jan 13th, 2025 12:00 pm
FDA Accepts Agios' sNDA for Pyrukynd in Thalassemia - Jan 9th, 2025 1:14 pm
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia - Jan 8th, 2025 12:00 pm
How to Navigate the Stock and Bond Markets in 2025 - Jan 3rd, 2025 3:00 pm
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025 - Jan 3rd, 2025 12:00 pm
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease - Dec 18th, 2024 12:00 pm
Here's Why Agios Stock Plummeted More Than 20% on Monday - Dec 10th, 2024 3:46 pm
Agios Pharmaceuticals price target raised to $75 from $53 at Scotiabank - Dec 10th, 2024 2:39 pm
Agios Crashes 21% After A Surprise Side Effect Hammered Its 'Very Safe' Drug - Dec 9th, 2024 9:21 pm
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat - Dec 8th, 2024 5:40 pm
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? - Dec 6th, 2024 4:31 pm
Are Options Traders Betting on a Big Move in Agios (AGIO) Stock? - Dec 5th, 2024 1:42 pm
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios - Dec 5th, 2024 10:00 am
4 Medical Product Stocks to Buy From a Prospective Industry - Dec 4th, 2024 2:42 pm
Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? - Nov 26th, 2024 2:40 pm
Agios Pharmaceuticals (NASDAQ:AGIO) Is Posting Healthy Earnings, But It Is Not All Good News - Nov 7th, 2024 11:57 am
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition - Nov 5th, 2024 2:05 pm
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down - Nov 1st, 2024 2:47 pm
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - Nov 1st, 2024 1:40 pm